Thrombin Activatable Fibrinolysis Inhibitor Antigen Levels Are Inversely Correlated with Plasminogen Activator Inhibitor-1 Antigen Levels in Hyperthyroid Patients-Reference-Cited by-同舟云学术

Thrombin Activatable Fibrinolysis Inhibitor Antigen Levels Are Inversely Correlated with Plasminogen Activator Inhibitor-1 Antigen Levels in Hyperthyroid Patients

Published:2007 Issue:4 Volume:54 Page:593-599
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

AKINCI Baris¹,COMLEKCI Abdurrahman¹,YENER Serkan¹,DEMIR Tevfik¹,OZCAN Mehmet Ali²,BAYRAKTAR Firat¹,YESIL Sena¹

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Dokuz Eylul University Medical School

2. Division of Haematology, Department of Internal Medicine, Dokuz Eylul University Medical School

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/54/4/54_4_593/_pdf

Reference29 articles.

1. 1. Vaughan DE (2005) PAI-1 and atherothrombosis. J Thromb Haemost 3: 1879-1883.

2. 2. Hamsten A, Eriksson P (1995) Fibrinolysis and atherosclerosis. Baillieres Clin Haematol 8: 345-363.

3. 3. Haverkate F (2002) Levels of haemostatic factors, arteriosclerosis and cardiovascular disease. Vascul Pharmacol 39: 109-112.

4. Coagulation disorders in thyroid diseases

5. 5. Presti CF, Hart RG (1989) Thyrotoxicosis, atrial fibrillation, and embolism, revisited. Am Heart J 117: 976-977.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemostasis in Overt and Subclinical Hyperthyroidism;International Journal of Endocrinology and Metabolism;2017-04-23

2. Activity of thrombin-activatable fibrinolysis inhibitor in the plasma of patients with abdominal aortic aneurysm;Blood Coagulation & Fibrinolysis;2014-04

3. Endothelial dysfunction in Graves' disease;Advances in Medical Sciences;2013-06

4. The Changes in the Endothelial Function and Haemostatic and Inflammatory Parameters in Subclinical and Overt Hyperthyroidism;International Journal of Endocrinology;2013

5. Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia;Thrombosis and Haemostasis;2013